Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Significant Decline in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 79,768 shares, a drop of 34.4% from the April 15th total of 121,549 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 777,518 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CLPBY shares. Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Coloplast A/S Stock Performance

Shares of Coloplast A/S stock opened at $6.13 on Monday. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. The stock has a market capitalization of $13.81 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 1.94 and a beta of 0.15. The stock has a 50 day moving average price of $6.66 and a two-hundred day moving average price of $7.91. Coloplast A/S has a 52 week low of $6.10 and a 52 week high of $10.03.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. As a group, equities analysts anticipate that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.